Such a well run company. We expected the expenses to increase with the ramp up of NNZ-2591 but it's just unreal our net FX gain for the quarter has covered our entire R&D spend over that same period. Another thing to note, it is good to see that the staff & general corporate expenses remaining reasonable (as a %) compared to our R&D spend which is a good sign.
Ann: Q3 2023 quarterly activity and cash flow report, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.08 |
Change
0.225(1.75%) |
Mkt cap ! $1.635B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $4.889M | 372.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 148 | $13.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.08 | 1213 | 9 |
View Market Depth
| Last trade - 13.17pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |